Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma
Top Cited Papers
- 14 March 2018
- journal article
- research article
- Published by IOS Press in Cancer Biomarkers
- Vol. 21 (4), 859-868
- https://doi.org/10.3233/CBM-170791
Abstract
In China, hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer and the leading cause of cancer death in men, followed by lung and stomach cancer. There was an urgent need to identify novel prognostic biomarkers for HCC. We explored thKeywords
This publication has 42 references indexed in Scilit:
- A link between FTO, ghrelin, and impaired brain food-cue responsivityJCI Insight, 2013
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse FertilityMolecular Cell, 2013
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- Overexpression of Fto leads to increased food intake and results in obesityNature Genetics, 2010
- Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitroHepatology, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1Biochemical Journal, 2006
- RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblastsOncogene, 2004